Catterton Partners Acquires Leading Cosmeceutical Brand ...( GREENWICH Conn. Jul...),Health

GREENWICH, Conn., July 13 /PRNewswire/ -- Catterton Partners, one of the nation's leading consumer-focused private equity firms, today announced that, through a holding company, it has acquired the StriVectin brand and related assets from affiliates of Klein-Becker. Chrysallis, the premier management team in the beauty and personal care industry, led by Chief Executive Officer Melisse Shaban and Chief Marketing Officer Jill Scalamandre, will lead the new company. The partnership between Catterton and the Chrysallis management team marks another in a number of successful endeavors between the two groups, the most notable of which was Frederic Fekkai & Co., which was sold in 2008.

StriVectin is a leader in the global skincare market, which is expected to reach $58.2 billion by 2012, an increase of 17.6% since 2007.(1) Lauded as the "stretch-mark cream turned anti-wrinkle phenomenon" since being introduced in 2003, StriVectin is the fastest growing anti-aging brand and one of the top 20 prestige skincare brands in the United States.(2) Its clinically proven formulations have earned the enthusiasm of millions of consumers and top honors at the "Les Grands Prix Advantages de la Beaute" (Advantages Grand Prix of Beauty) in Paris. Today, the StriVectin line encompasses a range of anti-aging products with a targeted, problem-solution positioning, including StriVectin(R) Instant Facial Sculpting Cream, StriVectin-SD(R) Eye Cream, StriVectin(R) Neck Cream, and StriVectin(R)-WF Instant Deep Wrinkle Filler. StriVectin products are sold through leading retailers as well as direct marketing channels around the world, with the largest presence in the United States, France and the United Kingdom.

"The skincare market is no longer about aspirational luxury; it's about what works and in this regard, we see tremendous value in the StriVectin brand," said Ms. Shaban.

"StriVe
'/>"/>